Your browser doesn't support javascript.
loading
Fulvestrant falsely elevates oestradiol levels in immunoassays in postmenopausal women with breast cancer.
Samuel, E; Chiang, C; Jennens, R; Faulkner, D; Francis, P A.
Afiliação
  • Samuel E; Department of Medical Oncology, Monash Health, Melbourne, Australia.
  • Chiang C; Department of Medicine, Peter MacCallum Cancer Center, Melbourne, Australia; Department of Endocrinology and Pathology, Royal Melbourne Hospital, University of Melbourne, Parkville, Australia.
  • Jennens R; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Faulkner D; Department of Biochemistry, Peter MacCallum Cancer Center, Melbourne, Australia.
  • Francis PA; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia. Electronic address: prue.francis@petermac.org.
Eur J Cancer ; 126: 104-105, 2020 02.
Article em En | MEDLINE | ID: mdl-31927211
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Imunoensaio / Pós-Menopausa / Estradiol / Fulvestranto Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Imunoensaio / Pós-Menopausa / Estradiol / Fulvestranto Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article